Targeted focal therapy for prostate cancer: A review of the literature

Therapeutic Advances in Urology

Volumn 1, Issue 3, 2009, Pages 149-159

  Sullivan, Kathryn F ^a   Crawford, E David ^a  

^a Anschutz Cancer Center   (United States)

Author keywords

cryotherapy; digital rectal examination; prostate cancer; PSA screening; targeted focal therapy (TFT); transrectal ultrasound

Indexed keywords

EID: 84993734467     PISSN: 17562872     EISSN: None     Source Type: Journal    
DOI: 10.1177/1756287209338708     Document Type: Review

References (29)

1. Babaian, R.J., Donnelly, B., Bahn, D., Baust, J.G., Dineen, M., Ellis, D. et al. (2008) Best Practice Statement on Cryosurgery for the Treatment of Localized Prostate Cancer. J Urol 180: 1993-2004.
2. Bahn, D.K., Silverman, P., Lee Sr, F., Badalament, R., Bahn, E.D. and Rewcastle, J.C. (2006) Focal prostate cryoablation: Initial results show cancer control and potency preservation. J Endourol 20(9): 688-692.
3. Barzell, W.E., Whitmore III, W.F. and Andriole, G.L. (2003) How to perform transperineal saturation prostate biopsy: technique addresses diagnostic, therapeutic dilemmas that arise following TRUS biopsies. Urology Times 31: 41.
4. Bastacky, S.I., Wonjno, K.U., Walsh, P.C., Carmichael, M.J. and Epstein, J.I. (1995) Pathological features of hereditary prostate cancer. J Urol 153: 987-992.
5. Crawford, E.D. and Barqawi, A. (2007) Targeted Focal Therapy: A minimally invasive Ablation Technique for Early Prostate Cancer. Oncology 21(1): 27-32.
6. Crawford, E.D., Wilson, S.S., Torkko, K.C., Hirano, D., Stewart, J.S., Brammell, C. et al. (2005) Clinical staging of prostate cancer: A computer-simulated study of transperineal prostate biopsy. BJU Int 96(7): 999-1004.
7. Djavan, B., Susani, M., Bursa, B., Basharkhah, A., Simak, R. and Marberger, M. (1999) Predictability and significance of multifocal prostate cancer in the radical prostatectomy specimen. Tech Urol 5(3): 139-142.
8. Dugan, J.A., Bostwick, D.G., Myers, R.P., Qian, J., Bergstralh, E.J. and Oesterling, J.E. (1996) The definition and preoperative prediction of clinically insignificant prostate cancer. JAMA 276: 288-294.
9. Etzioni, R., Penson, D.F., Legler, J.M., di Tommaso, D., Boer, R., Gann, P.H. et al. (2002) Overdiagnosis due to prostate-specific antigen screening: Lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 94: 981-990.
10. Han, K.R. and Belldegrun, A.S. (2004) Third-generation cryosurgery for primary and recurrent prostate cancer. BJU Int 93: 14-18.
11. Hsu, C.Y., Joniau, S., Oyen, R., Roskams, T. and Van Poppel, H. (2007) Outcome of surgery for clinical unilateral T3a prostate cancer: A single-institution experience. Eur Urol 51(1): 121-128.
12. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J. and Thun, M. (2007) Cancer statistics, 2007. CA Cancer J Clin 57: 43-66.
13. Kurhanewicz, J., Vigneron, D., Carroll, P. and Coakley, F. (2008) Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol 18(1): 71-77.
14. Lambert, E.H., Bolte, K., Masson, P. and Katz, A.E. (2007) Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology 69(6): 1117-1120.
15. Mouraviev, V., Nosnik, I., Sun, L., Robertson, C.N., Walther, P., Albala, D. et al. (2007a) Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: A single-institution experience. Urology 69(2): 311-314.
16. Mouraviev, V., Mayes, J.M., Sun, L., Madden, J.F., Moul, J.W. and Polascik, T.J. (2007b) Prostate cancer laterality as a rationale for focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer 110(4): 906-910.
17. Noguchi, M., Stamey, T.A., McNeal, J.E. and Nolley, R. (2003) Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: Lack of significance of secondary cancers. J Urol 170: 459-463.
18. Onik, G., Narayan, P., Vaughan, D., Dineen, M. and Brunelle, R. (2002) Focal“nerve-sparing” cryosurgery for treatment of primary prostate cancer: A new approach to preserving potency. Urology 60(1): 109-114.
19. Onik, G. (2008) Rationale for a ‘‘Male Lumpectomy–– a prostate cancer targeted approach using cryoablation: results in 21 patients with at least 2 years of follow-up. Cardiovasc Intervent Radiol 31(1): 98-106.
20. Onik, G., Vaughan, D., Lotenfoe, R., Dineen, M. and Brady, J. (2008) The ‘‘male lumpectomy––: Focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol 26(5): 500-505.
21. Presti, J.C., O–Dowd, G.J., Miller, C., Mattu, R. and Veltri, R. (2003) Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol 169(1): 125-129.
22. Puech, P., Huglo, D., Petyt, G., Lemaitre, L. and Villers, A. (2009) Imaging of organ-confined prostate cancer: functional ultrasound, MRI and PET/computed tomography. Curr Opin Urol 19(2): 168-176.
23. Rukstalis, D.B., Goldknopf, J.L., Crowley, E.M. and Garcia, F.U. (2002) Prostate cryoablation: A scientific rationale for future modifications. Urology 60: 19-25.
24. Scattoni, V., Zlotta, A., Montironi, R., Schulman, C., Rigatti, P. and Montorsi, F. (2007) Extended and saturation prostatic biopsy in the Diagnosis and Characterization of Prostate Cancer: A Critical Analysis of the Liturature. Eur Urol 52: 1309-1322.
25. Stamey, T.A., Freiha, F.S., McNeal, J.E., Redwine, E.A., Whittemore, A.S. and Schmid, H.P. (1993) Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 71: 933-938.
26. Villers, A., McNeal, J.E., Freiha, F.S. and Stamey, T.A. (1992) Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer 70(9): 2313-2318.
27. Villers, A., Puech, P., Mouton, D., Leroy, X., Ballereau, C. and Lemaitre, L. (2006) Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 176: 2432-2437.
28. Yoon, G.S., Wang, W., Osunkoya, A.O., Lane, Z., Partin, A.W. and Epstein, J.I. (2008) Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma. J Urol 179(6): 2203-2206.
29. Zelhof, B., Lowry, M., Rodrigues, G., Kraus, S. and Turnbull, L. (2009) Description of magnetic resonance imaging derived enhancement variables in pathologically confirmed prostate cancer and normal peripheral zone regions. BJU Int 103(7): 883-888.